InvestorsHub Logo
icon url

jakedogman1

06/18/13 4:12 PM

#128253 RE: honestabe13 #128250

"and this is clearly a trader's stock...."

when you have the ceo and puppet master controlling an investment firm with both a penny stock focus and offshore buds, what would you expect? I am also surprised at the lack of communication on the dose switching.... aw shucks.... someone made some money knowing the script.... who wrote it?
icon url

believer20

06/18/13 4:36 PM

#128257 RE: honestabe13 #128250

Bravo...I gree 100percent...I mentioned a friend who lost close to fifteen years ago and was told partnership then and has followed all the bs partnering talk since. Only to be bashed of the truth...The truth is right in front of our eyes..Again they just dont have the goods..1.50 stock?? Should be waaaaay higher if they got what it takes.
icon url

dia76ca

06/18/13 5:11 PM

#128270 RE: honestabe13 #128250

Even though I am a Canadian I will not apologize for being happy about PPHM( CANADIANS APOLOGIZE IF SOMEONE STEPS ON THEIR TOES)! I HATE CANCER AND I AM HAPPY TO SEE IT DEFEATED! And I just consistently face reality. I buy PPHM shares when they are low and sell when they are high. I am way up on PPHM. I bought a lot of shares when one poster said PPHM was a scam and going bankrupt. I bought more when he said that PPHM would NEVER get FDA approval for the second line NSCLC trial, indeed that they would not even present the data to the FDA!

King and the BOD made a great decision in getting Dr. Garnick as part of the team. They obviously were clever enough to follow his strategy of going after difficult cancer indications...and using Bavi with a variety of SOC! It was not their fault that the CRO screwed up...but they salvaged the data and got FDA approval... great job on their part!

I look forward to Bavi being approved for NSCLC, breast and liver cancer. And I think it will also get approvals in pancreatic and prostate, ovarian and colon indications with the proper combinations. I also look forward to trials of Bavi with the new PD-1's if they turn out to be safe and efficacious...and in combination with the whole new generation of immunologics.

And who cannot be excited about the potential in imaging and the second generation of loaded Mabs and betabodies. And while the viral studies have been handed to others...I look forward to the potential of betabodies in the viral application! And all of this with that great asset which so many overlook...AVID.

PPHM are not the scam artists. The critics are. They want our shares...and they want them cheap. I am confident there will be a partnership this year (maybe next week or next month for all I know). If I did not believe this I would sell. You and I don't know whether their doors are being beaten down by potential partners or not. Personally I think that there is more than one BP that is intelligent enough to want to partner with PPHM...but all it takes is one...and a partnership will change everyones perception of Peregrine.